These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

706 related articles for article (PubMed ID: 24176710)

  • 1. Occurrence, fate and ecotoxicological assessment of pharmaceutically active compounds in wastewater and sludge from wastewater treatment plants in Chongqing, the Three Gorges Reservoir Area.
    Yan Q; Gao X; Chen YP; Peng XY; Zhang YX; Gan XM; Zi CF; Guo JS
    Sci Total Environ; 2014 Feb; 470-471():618-30. PubMed ID: 24176710
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Occurrence and fate of pharmaceutically active compounds in the largest municipal wastewater treatment plant in Southwest China: mass balance analysis and consumption back-calculated model.
    Yan Q; Gao X; Huang L; Gan XM; Zhang YX; Chen YP; Peng XY; Guo JS
    Chemosphere; 2014 Mar; 99():160-70. PubMed ID: 24268750
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Assessing the removal of pharmaceuticals and personal care products in a full-scale activated sludge plant.
    Salgado R; Marques R; Noronha JP; Carvalho G; Oehmen A; Reis MA
    Environ Sci Pollut Res Int; 2012 Jun; 19(5):1818-27. PubMed ID: 22207237
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Fate and distribution of pharmaceuticals in wastewater and sewage sludge of the conventional activated sludge (CAS) and advanced membrane bioreactor (MBR) treatment.
    Radjenović J; Petrović M; Barceló D
    Water Res; 2009 Feb; 43(3):831-41. PubMed ID: 19091371
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Occurrence of pharmaceutical compounds in wastewater and sludge from wastewater treatment plants: removal and ecotoxicological impact of wastewater discharges and sludge disposal.
    Martín J; Camacho-Muñoz D; Santos JL; Aparicio I; Alonso E
    J Hazard Mater; 2012 Nov; 239-240():40-7. PubMed ID: 22608399
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmaceutically active compounds in sludge stabilization treatments: anaerobic and aerobic digestion, wastewater stabilization ponds and composting.
    Martín J; Santos JL; Aparicio I; Alonso E
    Sci Total Environ; 2015 Jan; 503-504():97-104. PubMed ID: 24909712
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Occurrence and indicators of pharmaceuticals in Chinese streams: A nationwide study.
    Yao B; Yan S; Lian L; Yang X; Wan C; Dong H; Song W
    Environ Pollut; 2018 May; 236():889-898. PubMed ID: 29042137
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Analysis and advanced oxidation treatment of a persistent pharmaceutical compound in wastewater and wastewater sludge-carbamazepine.
    Mohapatra DP; Brar SK; Tyagi RD; Picard P; Surampalli RY
    Sci Total Environ; 2014 Feb; 470-471():58-75. PubMed ID: 24140682
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Estrogenic compounds in Tunisian urban sewage treatment plant: occurrence, removal and ecotoxicological impact of sewage discharge and sludge disposal.
    Belhaj D; Athmouni K; Jerbi B; Kallel M; Ayadi H; Zhou JL
    Ecotoxicology; 2016 Dec; 25(10):1849-1857. PubMed ID: 27660067
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Occurrence and removal of pharmaceutically active compounds in sewage treatment plants with different technologies.
    Ying GG; Kookana RS; Kolpin DW
    J Environ Monit; 2009 Aug; 11(8):1498-505. PubMed ID: 19657534
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Occurrence and fate of typical antibiotics in a wastewater treatment plant in Southwest China].
    Gan XM; Yan Q; Gao X; Zhang YX; Zi CF; Peng XY; Guo JS
    Huan Jing Ke Xue; 2014 May; 35(5):1817-23. PubMed ID: 25055672
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmaceuticals as chemical markers of wastewater contamination in the vulnerable area of the Ebro Delta (Spain).
    Čelić M; Gros M; Farré M; Barceló D; Petrović M
    Sci Total Environ; 2019 Feb; 652():952-963. PubMed ID: 30380500
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Occurrence and fate of pharmaceutically active compounds in the environment, a case study: Höje River in Sweden.
    Bendz D; Paxéus NA; Ginn TR; Loge FJ
    J Hazard Mater; 2005 Jul; 122(3):195-204. PubMed ID: 15967274
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Occurrence of pharmaceuticals in a municipal wastewater treatment plant: mass balance and removal processes.
    Gao P; Ding Y; Li H; Xagoraraki I
    Chemosphere; 2012 Jun; 88(1):17-24. PubMed ID: 22494528
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Understanding the distribution, degradation and fate of organophosphate esters in an advanced municipal sewage treatment plant based on mass flow and mass balance analysis.
    Liang K; Liu J
    Sci Total Environ; 2016 Feb; 544():262-70. PubMed ID: 26657372
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Distribution, mass load and environmental impact of multiple-class pharmaceuticals in conventional and upgraded municipal wastewater treatment plants in East China.
    Yuan X; Qiang Z; Ben W; Zhu B; Qu J
    Environ Sci Process Impacts; 2015 Mar; 17(3):596-605. PubMed ID: 25614232
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The role of sorption processes in the removal of pharmaceuticals by fungal treatment of wastewater.
    Lucas D; Castellet-Rovira F; Villagrasa M; Badia-Fabregat M; Barceló D; Vicent T; Caminal G; Sarrà M; Rodríguez-Mozaz S
    Sci Total Environ; 2018 Jan; 610-611():1147-1153. PubMed ID: 28847135
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Assessment of multiclass pharmaceutical active compounds (PhACs) in hospital WWTP influent and effluent samples by UHPLC-Orbitrap MS: Temporal variation, removals and environmental risk assessment.
    Kosma CI; Kapsi MG; Konstas PG; Trantopoulos EP; Boti VI; Konstantinou IK; Albanis TA
    Environ Res; 2020 Dec; 191():110152. PubMed ID: 32877707
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Linking microbial diversity and population dynamics to the removal efficiency of pharmaceutically active compounds (PhACs) in an anaerobic/anoxic/aerobic (A
    Gallardo-Altamirano MJ; Maza-Márquez P; Montemurro N; Rodelas B; Osorio F; Pozo C
    Chemosphere; 2019 Oct; 233():828-842. PubMed ID: 31200141
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of advanced biological treatment and nature-based solutions for the treatment of pharmaceutically active compounds (PhACs): A comprehensive study for wastewater and sewage sludge.
    Nas B; Dolu T; Argun ME; Yel E; Ateş H; Koyuncu S
    Sci Total Environ; 2021 Jul; 779():146344. PubMed ID: 34030227
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 36.